Dicycloverine
| Clinical data | |
|---|---|
| Trade names | Byclomine, Bentyl, Dibent, others | 
| AHFS/Drugs.com | Monograph | 
| MedlinePlus | a684007 | 
| License data | 
 | 
| Pregnancy category | 
 | 
| Routes of administration | By mouth, intramuscular | 
| Drug class | Antimuscarinic | 
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Protein binding | >99% | 
| Elimination half-life | 5 hours | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.919 | 
| Chemical and physical data | |
| Formula | C19H35NO2 | 
| Molar mass | 309.494 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
| (verify) | |
Dicycloverine, also known as dicyclomine, sold under the brand name Bentyl among others, is a medication that is used to treat spasms of the intestines such as those that occur in irritable bowel syndrome (IBS). It is taken by mouth or by injection into a muscle. While it has been used in baby colic and enterocolitis, evidence does not support these uses.
Common side effects include dry mouth, blurred vision, weakness, sleepiness, and lightheadedness. Serious side effects may include psychosis and breathing problems in babies. Use in pregnancy appears to be safe while use during breastfeeding is not recommended. How it works is not entirely clear.
Dicycloverine was approved for medical use in the United States in 1950. It is available as a generic medication. In 2022, it was the 176th most commonly prescribed medication in the United States, with more than 2 million prescriptions.